AI agents have moved from pilots to practice: 14% of large enterprises report partial or full deployments and 23% are piloting, according to the “Rise of agentic AI” report from Capgemini. But as adoption ticks up, trust in fully autonomous agents slid from 43% to 27% over the past year. What does that mix mean… The post AI agents are proliferating in pharma, but taming them may be the next frontier appeared first on Drug Discovery and Development.
